General Information of the Compound
| Compound ID |
CP0029912
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Aralen
Show/Hide
|
||||||||||||||||||
| Synonyms |
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
Bemaco
Bemaphate
Bemasulph
Benaquin
Bipiquin
CU-01000012392-2
Capquin
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine Bis-Phosphoric Acid
Chloroquine FNA (TN)
Chloroquine [USAN:INN:BAN]
Chloroquine phosphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
Dawaquin (TN)
Delagil
Dichinalex
Elestol
Gontochin
Gontochin phosphate
Heliopar
Imagon
Ipsen 225
Iroquine
Khingamin
Klorokin
Lapaquin
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
Neochin
Nivachine
Nivaquine B
Pfizerquine
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
RP 3377
RP-3377
Resochen
Resochin
Resochin (TN)
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
SN 6718
SN-7618
ST 21
ST 21 (pharmaceutical)
Sanoquin
Silbesan;Siragan
Solprina
Sopaquin
Tanakan
Tanakene
Tresochin
Trochin
W 7618;WIN 244
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H26ClN3
|
||||||||||||||||||
| Molecular Weight |
319.88
|
||||||||||||||||||
| Canonical SMILES |
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WHTVZRBIWZFKQO-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
58175-86-3
58175-87-4
56598-66-4
54-05-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01151, Amyloid-beta precursor protein
Protein ID: PT01020, Beta-secretase 1
Protein ID: PT02591, Major prion protein
Protein ID: PT05155, Nuclear receptor subfamily 4 group A member 2
Clinical Information about the Compound
Drug 1 ( Chloroquine )
| Drug Name | Chloroquine | ||
|---|---|---|---|
| Company | Medreich Sterilab Ltd | ||
| Indication | |||
| Target(s) | |||